#PortfolioNews | SpliceBio doses the first patient in the Phase 1/2 ASTRA study of SB-007, the first dual AAV #GeneTherapy for #StargardtDisease!

🎯 Showcasing the power of #ProteinSplicing to tackle diseases caused by #LargeGenes mutations.

👉 buff.ly/HvB3bPR

#VC